|

AVA6000 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Avacta Life Sciences Ltd1

Indications

  • Salivary Gland Tumor1
  • Urothelial Carcinoma1
  • Ovarian Carcinoma1
  • Soft Tissue Sarcoma1
  • Breast Cancer1

New York, New York1 trial

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Memorial Sloan Kettering Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.